Anti-PKC eta antibody [EPR18513]
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(1 Review)
|
(11 Publications)
Rabbit Recombinant Monoclonal KPCL antibody. Suitable for IP, WB and reacts with Mouse, Rat, Human samples. Cited in 11 publications.
View Alternative Names
PKCL, PRKCL, PRKCH, Protein kinase C eta type, PKC-L, nPKC-eta
- IP
Supplier Data
Immunoprecipitation - Anti-PKC eta antibody [EPR18513] (AB179524)
PKC eta was immunoprecipitated from 1mg of Mouse lung whole cell lysate with ab179524 at 1/50 dilution. Western blot was performed from the immunoprecipitate using ab179524 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : Mouse lung whole cell lysate 10ug (Input).
Lane 2 : ab179524 IP in Mouse lung whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab179524 in Mouse lung whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
All lanes:
Immunoprecipitation - Anti-PKC eta antibody [EPR18513] (ab179524)
Predicted band size: 78 kDa
Observed band size: 40 kDa,78 kDa
false
- WB
Supplier Data
Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
Blocking/Dilution buffer : 5% NFDM/TBST.
The antibody recognizes the full length (~78KD) and the catalytic domain (~40KD) of PKC eta.
(Geraldes P and King GL, 2010. Circ Res. 106, 1319-1331; Newton AC. 1995. J. Biol. Chem. 270, 28495-28498)
All lanes:
Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/10000 dilution
Lane 1:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 10 µg
Lane 2:
PC-3 (Human prostate adenocarcinoma cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 78 kDa
Observed band size: 45 kDa,78 kDa
false
Exposure time: 1min
- WB
Supplier Data
Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
Blocking/Dilution buffer : 5% NFDM/TBST.
The antibody recognizes the full length (~78KD) and the catalytic domain (~40KD) of PKC eta.
(Geraldes P and King GL, 2010. Circ Res. 106, 1319-1331; Newton AC, 1995. J. Biol. Chem. 270, 28495-28498)
All lanes:
Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/2000 dilution
Lane 1:
Human fetal brain lysate at 10 µg
Lane 2:
Human fetal heart lysate at 10 µg
Lane 3:
Human fetal kidney lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/50000 dilution
Predicted band size: 78 kDa
Observed band size: 45 kDa,78 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
Blocking/Dilution buffer : 5% NFDM/TBST.
The antibody recognizes the full length (~78KD) and the catalytic domain (~40KD) of PKC eta.
(Geraldes P and King GL, 2010. Circ Res. 106, 1319-1331; Newton AC, 1995. J. Biol. Chem. 270, 28495-28498)
All lanes:
Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/10000 dilution
Lane 1:
Human fetal skin lysate at 10 µg
Lane 2:
Mouse lung lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 78 kDa
Observed band size: 45 kDa,78 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
Blocking/Dilution buffer : 5% NFDM/TBST.
Active human PKC alpha full length protein (ab55672) contains aa1-672 with GST-tag; Active human PKC beta 1 full length protein (ab60840) contains aa1-671 with GST-tag; Active human PKC beta 2 full length protein (ab60841) contains aa1-673 with GST-tag; Active human PKC gamma full length protein(ab60842) contains aa1-677 with GST-tag; Active human PKC delta full length protein (ab60844) contains aa1-676 with GST-tag; Active human PKC eta full length protein (ab60849) contains aa1-683 with GST-tag; Active human PKC epsilon full length protein (ab60847) contains aa1-737 with GST-tag; Active human PKC theta full length protein (ab56641) contains aa1-706 with GST-tag; Active human PKC mu full length protein (ab60873) contains aa1-912 with GST-tag.
All lanes:
Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/2000 dilution
Lane 1:
Active human PKC alpha full length protein at 0.02 µg
Lane 2:
Active human PKC beta 1 full length protein at 0.02 µg
Lane 3:
Active human PKC beta 2 full length protein at 0.02 µg
Lane 4:
Active human PKC gamma full length protein at 0.02 µg
Lane 5:
Active human PKC delta full length protein at 0.02 µg
Lane 6:
Active human PKC eta full length protein at 0.02 µg
Lane 7:
Active human PKC epsilon full length protein at 0.02 µg
Lane 8:
Active human PKC theta full length protein at 0.02 µg
Lane 9:
Active human PKC mu full length protein at 0.02 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 78 kDa
false
Exposure time: 1s
- WB
Lab
Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
Western blot : Rabbit Monoclonal [EPR18513] to PKC ab179524 staining at 1/2000 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 76, 85 kDa in Wild-type A549 cell lysates with no signal observed at this size in PRKCH knockout A549 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween™ 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/2000 dilution
Lane 1:
Wild-type A549 whole cell lysate at 20 µg
Lane 2:
PRKCH knockout A549 whole cell lysate at 20 µg
Lane 3:
U-2 OS whole cell lysate at 20 µg
Lane 4:
HL-60 whole cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 78 kDa
Observed band size: 76 kDa,85 kDa
false
- WB
Supplier Data
Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
Blocking/Dilution buffer : 5% NFDM/TBST.
The antibody recognizes the full length (~78KD) and the catalytic domain (~40KD) of PKC eta.
(Geraldes P and King GL, 2010. Circ Res. 106, 1319-1331; Newton AC, 1995. J. Biol. Chem. 270, 28495-28498)
All lanes:
Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/2000 dilution
Lane 1:
Rat skin lysate at 10 µg
Lane 2:
Mouse skin lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 78 kDa
Observed band size: 45 kDa,78 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
Blocking/Dilution buffer : 5% NFDM/TBST.
The antibody recognizes the full length (~78KD) and the catalytic domain (~40KD) of PKC eta.
(Geraldes P and King GL, 2010. Circ Res. 106, 1319-1331; Newton AC, 1995. J. Biol. Chem. 270, 28495-28498)
All lanes:
Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/10000 dilution
Lane 1:
Mouse brain lysate at 10 µg
Lane 2:
Rat brain lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 78 kDa
Observed band size: 45 kDa,78 kDa
false
Exposure time: 30s
Related conjugates and formulations (1)
-
Anti-PKC eta antibody [EPR18513] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PKC eta involves itself in cellular differentiation and proliferation. It is a component of signal transduction complexes that mediate these processes. In epithelial cells PKC eta modulates cell adhesion and integrity. It also affects immune responses through its action in T-cells and other immune components impacting both innate and adaptive immunity. The enzyme interacts closely with other PKC isoforms allowing it to regulate diverse biological functions through complex networks.
Pathways
PKC eta plays an integral role in growth factor and cytokine signaling pathways. MAPK/ERK and PI3K/AKT pathways include PKC eta as key components for cell survival and proliferation. These pathways facilitate interactions and regulation involving proteins like RAF-1 and AKT coordinating cell growth and apoptosis. PKC eta's positioning in these pathways denotes its significance in maintaining cellular homeostasis and responding to external stimuli.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Molecular medicine reports 32: PubMed40280116
2025
Applications
Unspecified application
Species
Unspecified reactive species
eLife 13: PubMed39932433
2025
Applications
Unspecified application
Species
Unspecified reactive species
MedComm 5:e737 PubMed39309696
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 298:102466 PubMed36087841
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34884454
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal for immunotherapy of cancer 9: PubMed34588224
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 11:553852 PubMed33584253
2021
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmaceutica Sinica. B 11:71-88 PubMed33532181
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular pharmacology 99:104-113 PubMed33239332
2020
Applications
Unspecified application
Species
Unspecified reactive species
Glia 69:697-714 PubMed33068318
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com